These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31611144)

  • 21. Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada.
    Noiles K; Vender R
    J Cutan Med Surg; 2010; 14(3):105-14. PubMed ID: 20487670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palatability and Stability Studies to Optimize a Carvedilol Oral Liquid Formulation for Pediatric Use.
    Chiclana-Rodríguez B; Garcia-Montoya E; Romero-Obon M; Rouaz-El-Hajoui K; Nardi-Ricart A; Suñé-Pou M; Suñé-Negre JM; Pérez-Lozano P
    Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation on the rational use of antibacterial agents by Chinese pediatricians in 2016].
    National Health and Family Planning Commission Expert Committee on Rational Use of Medicines for Children Pharmaceutical Group
    Zhonghua Er Ke Za Zhi; 2018 Dec; 56(12):897-906. PubMed ID: 30518003
    [No Abstract]   [Full Text] [Related]  

  • 26. [STUDIES ON SYNTHETIC SWEETENING AGENTS. IV. ON THE COLORING MATTER IN COLORIMETRIC DETERMINATION OF SODIUM CYCLAMATE].
    ICHIKAWA M; KOJIMA S; ICHIBAGASE H
    Yakugaku Zasshi; 1964 Jun; 84():563-6. PubMed ID: 14207117
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of a stable oral liquid dosage form of spironolactone.
    Pramar Y; Das Gupta V; Bethea C
    J Clin Pharm Ther; 1992 Aug; 17(4):245-8. PubMed ID: 1429919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability.
    Matsui R; Uchida S; Namiki N
    Biol Pharm Bull; 2015; 38(1):17-22. PubMed ID: 25744453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation, characterization and taste-masking properties of microspheres containing azithromycin.
    Hu L; Pan J; Liu C; Xu H; Luo L
    J Pharm Pharmacol; 2009 Dec; 61(12):1631-5. PubMed ID: 19958585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
    Cantor SL; Khan MA; Gupta A
    Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate.
    Lopalco A; Curci A; Lopedota A; Cutrignelli A; Laquintana V; Franco M; Denora N
    Eur J Pharm Sci; 2019 Jan; 127():339-350. PubMed ID: 30447284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basics of compounding: Tips and hints, part 4: lollipops/lozenges, gummy bears, patches, flavoring/coloring, sweeteners, and packaging.
    Allen LV
    Int J Pharm Compd; 2014; 18(4):318-9. PubMed ID: 25474861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Industry Survey on Current Practices in the Assessment of Palatability and Swallowability in the Development of Pediatric Oral Dosage Forms.
    Thompson CA; Lombardi DP; Sjostedt P; Squires LA
    Ther Innov Regul Sci; 2013 Sep; 47(5):542-549. PubMed ID: 30235578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a taste-masked oral suspension of clindamycin HCl using ion exchange resin Amberlite IRP 69 for use in pediatrics.
    Alayoubi A; Daihom B; Adhikari H; Mishra S; Helms R; Almoazen H
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1579-89. PubMed ID: 26926148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.
    van der Vossen AC; van der Velde I; Smeets OS; Postma DJ; Eckhardt M; Vermes A; Koch BC; Vulto AG; Hanff LM
    Eur J Pharm Sci; 2017 Mar; 100():205-210. PubMed ID: 28126558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A survey of prescribing pattern of sugar-containing liquid oral medicines in pediatrics in a teaching hospital in north-eastern India.
    Das B; Sarkar C; Dutta S; Majumder AG
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):432-3. PubMed ID: 16739242
    [No Abstract]   [Full Text] [Related]  

  • 40. Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved.
    Allen LV
    Int J Pharm Compd; 2021; 25(5):396-400. PubMed ID: 34623966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.